Normal view
-
Cell
-
scBaseCount: An AI agent-curated, standardized, auto-updated single-cell data repository
scBaseCount is presently the largest public single-cell RNA-seq repository, containing over 502 million cells across 27 organisms and 75 tissues. An AI agent autonomously discovers, annotates, and uniformly reprocesses all 10× Genomics datasets in the SRA, creating a harmonized, continually updated resource for studying the diversity of cell biology and training AI models.
-
Cell
-
An open benchmark and language models for AI in aging biology
LongevityBench, Longevity-LLMs, and Longevity Claw evaluate the readiness of the state-of-the-art AI systems for spearheading aging research.
An open benchmark and language models for AI in aging biology
-
Nature Medicine
-
Liquid biopsy for early detection of pancreatic ductal adenocarcinoma
Nature Medicine, Published online: 16 September 2026; doi:10.1038/s41591-026-04625-xIn a prospective study involving 1,785 individuals from four countries, the PANXEON exosome-based biomarker, combined with carbohydrate antigen 19-9 levels, achieves high sensitivity for the detection of early-stage pancreatic cancer.
Liquid biopsy for early detection of pancreatic ductal adenocarcinoma
Nature Medicine, Published online: 16 September 2026; doi:10.1038/s41591-026-04625-x
In a prospective study involving 1,785 individuals from four countries, the PANXEON exosome-based biomarker, combined with carbohydrate antigen 19-9 levels, achieves high sensitivity for the detection of early-stage pancreatic cancer.-
Nature Medicine
-
Sex-specific biological aging clocks across organs and omics
Nature Medicine, Published online: 16 September 2026; doi:10.1038/s41591-026-04662-6Sex-specific biological aging clocks across multiple organs and molecular systems show that female and male aging patterns can differ in organ-specific, disease-relevant ways.
Sex-specific biological aging clocks across organs and omics
Nature Medicine, Published online: 16 September 2026; doi:10.1038/s41591-026-04662-6
Sex-specific biological aging clocks across multiple organs and molecular systems show that female and male aging patterns can differ in organ-specific, disease-relevant ways.-
Cell Death Discovery nature.com science feeds
-
rhNGF shows neuroprotective efficacy by counteracting oxidative stress and neuroinflammation in a glaucoma mouse model
Cell Death Discovery, Published online: 16 September 2026; doi:10.1038/s41420-026-03345-yrhNGF shows neuroprotective efficacy by counteracting oxidative stress and neuroinflammation in a glaucoma mouse model
rhNGF shows neuroprotective efficacy by counteracting oxidative stress and neuroinflammation in a glaucoma mouse model
Cell Death Discovery, Published online: 16 September 2026; doi:10.1038/s41420-026-03345-y
rhNGF shows neuroprotective efficacy by counteracting oxidative stress and neuroinflammation in a glaucoma mouse model-
Nature Medicine
-
Broadly neutralizing antibodies in adult males living with HIV undergoing analytical treatment interruption: secondary and exploratory outcomes of the phase II randomized controlled RIO trial
Nature Medicine, Published online: 15 September 2026; doi:10.1038/s41591-026-04644-8In the phase 2 RIO trial, there was delayed viral rebound and resistance to broadly neutralizing antibodies 3BNC117-LS and 10-1074-LS in adult males living with HIV undergoing analytical treatment interruption, and initial reservoir sensitivity to autologous antibodies was associated with a longer time to rebound.
Broadly neutralizing antibodies in adult males living with HIV undergoing analytical treatment interruption: secondary and exploratory outcomes of the phase II randomized controlled RIO trial
Nature Medicine, Published online: 15 September 2026; doi:10.1038/s41591-026-04644-8
In the phase 2 RIO trial, there was delayed viral rebound and resistance to broadly neutralizing antibodies 3BNC117-LS and 10-1074-LS in adult males living with HIV undergoing analytical treatment interruption, and initial reservoir sensitivity to autologous antibodies was associated with a longer time to rebound.-
Cell
-
4D spatiotemporal landscape of mitochondrial phenotypes across cellular states unlocked through representation learning
Agarwal et al. introduce MitoSpace, a self-supervised model trained on 4D lattice light-sheet microscopy data. The model resolves drug-induced mitochondrial phenotypes without labels, predicts membrane potential from morphology and dynamics, generalizes to unseen perturbations and lung organoids, and shows that representation quality improves progressively from 2D to 4D.
4D spatiotemporal landscape of mitochondrial phenotypes across cellular states unlocked through representation learning
-
Cell
-
Predicting cellular responses to perturbation across diverse contexts with State
Modeling perturbation effects across large single-cell populations requires flexibility to capture heterogeneity. By training over sets of cells in a shared embedding space, State outperforms baselines at generalizing effects to new contexts. Cell-Eval, the framework used for this comparison, provides a comprehensive benchmark for future models.
Predicting cellular responses to perturbation across diverse contexts with State
-
Cell
-
Fifteen challenges for generative AI applications to cell biology
Drawing inspiration from Hilbert’s list of 23 mathematical problems that have focused the mathematical community’s attention for more than a century, we propose fifteen grand AI challenges to focus the biomedical community’s attention on critically relevant questions, most of which still lack effective predictive methodologies.
Fifteen challenges for generative AI applications to cell biology
-
Cell
-
Spatial biology reveals altered macrophage states in immunosuppressed non-melanoma skin cancer
Spatial multi-omics reveals macrophage states that constrain adaptive immunity in immunosuppressed non-melanoma skin cancer.
Spatial biology reveals altered macrophage states in immunosuppressed non-melanoma skin cancer
-
Cell
-
Dietary arginine drives codon-dependent MHC class I translation and improves immunity in colon tumorigenesis and respiratory viral infection
Arginine availability regulates arginyl tRNA levels and codon-dependent translation of MHC class I, tuning antigen presentation and shaping anti-viral and anti-tumor immunity.
Dietary arginine drives codon-dependent MHC class I translation and improves immunity in colon tumorigenesis and respiratory viral infection
-
Cell
-
Spatial proximity sequencing maps developmental dynamics in the germinal center
Sprox-seq enables spatial profiling of protein complexes, surface proteins, and mRNAs in intact tissues by combining proximity ligation with spatial transcriptomics. In human tonsils, Sprox-seq maps germinal center interaction networks, links CD21-CD35 complexes to proliferative programs, reveals interaction-based B cell state transitions, and directly captures B cell-follicular dendritic cell communication.
Spatial proximity sequencing maps developmental dynamics in the germinal center
-
Nature - Issue - nature.com science feeds
-
Encoded and non-genetic protein variants expand human functional proteome
Nature, Published online: 14 September 2026; doi:10.1038/s41586-026-11124-zEncoded and non-genetic protein variants expand human functional proteome
Encoded and non-genetic protein variants expand human functional proteome
Nature, Published online: 14 September 2026; doi:10.1038/s41586-026-11124-z
Encoded and non-genetic protein variants expand human functional proteome-
npj Digital Medicine
-
Data-driven identification of repurposable drugs for ALS
npj Digital Medicine, Published online: 14 September 2026; doi:10.1038/s41746-026-03225-wData-driven identification of repurposable drugs for ALS
Data-driven identification of repurposable drugs for ALS
npj Digital Medicine, Published online: 14 September 2026; doi:10.1038/s41746-026-03225-w
Data-driven identification of repurposable drugs for ALS-
Nature Cancer
-
Circulating tumor DNA-guided de-escalation or escalation of adjuvant therapy in high-risk stage II and stage III colon cancer: the phase 2 PEGASUS trial
Nature Cancer, Published online: 14 September 2026; doi:10.1038/s43018-026-01237-9Marsoni et al. evaluated the feasibility of a dynamic circulating tumor DNA-guided adjuvant and postadjuvant treatment strategy in patients with resected microsatellite-stable, high-risk stage II or III colon cancer in the phase 2 PEGASUS trial.
Circulating tumor DNA-guided de-escalation or escalation of adjuvant therapy in high-risk stage II and stage III colon cancer: the phase 2 PEGASUS trial
Nature Cancer, Published online: 14 September 2026; doi:10.1038/s43018-026-01237-9
Marsoni et al. evaluated the feasibility of a dynamic circulating tumor DNA-guided adjuvant and postadjuvant treatment strategy in patients with resected microsatellite-stable, high-risk stage II or III colon cancer in the phase 2 PEGASUS trial.-
Nature Medicine
-
Rethinking the global health system for a new international order
Nature Medicine, Published online: 14 September 2026; doi:10.1038/s41591-026-04622-0In this Comment, we argue for a global health system that recognizes and supports countries as the primary agents of action, oriented around global public goods and collective action, and served by a leaner set of global and regional institutions. We present a potential vision for the functions and distribution of labor in the system to inform ongoing reform discussions and draw critique, dissent and amendment.
Rethinking the global health system for a new international order
Nature Medicine, Published online: 14 September 2026; doi:10.1038/s41591-026-04622-0
In this Comment, we argue for a global health system that recognizes and supports countries as the primary agents of action, oriented around global public goods and collective action, and served by a leaner set of global and regional institutions. We present a potential vision for the functions and distribution of labor in the system to inform ongoing reform discussions and draw critique, dissent and amendment.-
Nature Medicine
-
Prospective evidence for conversational medical AI is hard, but non-negotiable
Nature Medicine, Published online: 14 September 2026; doi:10.1038/s41591-026-04639-5Trust in clinical artificial intelligence (AI) cannot be benchmarked into existence. It must be earned through rigorous prospective studies in real-world clinical settings, where the hardest lessons often concern the humans and systems around the AI, not the technology itself.
Prospective evidence for conversational medical AI is hard, but non-negotiable
Nature Medicine, Published online: 14 September 2026; doi:10.1038/s41591-026-04639-5
Trust in clinical artificial intelligence (AI) cannot be benchmarked into existence. It must be earned through rigorous prospective studies in real-world clinical settings, where the hardest lessons often concern the humans and systems around the AI, not the technology itself.-
Nature Medicine
-
Clinical usability of an explainable AI decision support tool and evaluation of multimodal models in NSCLC
Nature Medicine, Published online: 13 September 2026; doi:10.1038/s41591-026-04488-2In a large international real-world study of non-small cell lung cancer, a multimodal explainable AI model outperformed established biomarkers for immunotherapy outcome prediction and improved physician decision-making.
Clinical usability of an explainable AI decision support tool and evaluation of multimodal models in NSCLC
Nature Medicine, Published online: 13 September 2026; doi:10.1038/s41591-026-04488-2
In a large international real-world study of non-small cell lung cancer, a multimodal explainable AI model outperformed established biomarkers for immunotherapy outcome prediction and improved physician decision-making.-
Nature Medicine
-
Teclistamab versus lenalidomide-dexamethasone in high-risk smoldering multiple myeloma: a randomized phase 2 trial
Nature Medicine, Published online: 11 September 2026; doi:10.1038/s41591-026-04642-wIn the randomized phase 2 ImmunoPRISM trial, patients with high-risk smoldering multiple myeloma (MM) showed higher rates of complete clinical responses in response to treatment with teclistamab compared with lenalidomide–dexamethasone, although longer follow-up is required to determine durable prevention of progression to MM.
Teclistamab versus lenalidomide-dexamethasone in high-risk smoldering multiple myeloma: a randomized phase 2 trial
Nature Medicine, Published online: 11 September 2026; doi:10.1038/s41591-026-04642-w
In the randomized phase 2 ImmunoPRISM trial, patients with high-risk smoldering multiple myeloma (MM) showed higher rates of complete clinical responses in response to treatment with teclistamab compared with lenalidomide–dexamethasone, although longer follow-up is required to determine durable prevention of progression to MM.-
Nature Medicine
-
Computable longitudinal patient journeys from structured and unstructured EHR data
Nature Medicine, Published online: 10 September 2026; doi:10.1038/s41591-026-04695-xA suite of large pre-trained language models accurately extracts computable clinical data from unstructured electronic health records and integrates the findings into knowledge graphs that can facilitate understanding patient trajectories and treatment responses in the real world.
Computable longitudinal patient journeys from structured and unstructured EHR data
Nature Medicine, Published online: 10 September 2026; doi:10.1038/s41591-026-04695-x
A suite of large pre-trained language models accurately extracts computable clinical data from unstructured electronic health records and integrates the findings into knowledge graphs that can facilitate understanding patient trajectories and treatment responses in the real world.